Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | VDR | P11473 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3315459 | 0.90 | GAA (0.52) | GAASTAT3ALDH1A1CYP3A4CYP2C9 | |
| Fluoride SCHEMBL31533364 | 0.88 | GAA (0.50) | GAASTAT3ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL11604749 | 0.86 | GAA (0.48) | GAASTAT3ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL10020918 | 0.84 | ALDH1A1 (0.45) | GAASTAT3ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL15000834 | 0.83 | ALDH1A1 (0.54) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL85631 | 0.82 | ALDH1A1 (0.50) | GAASTAT3ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL15661681 | 0.82 | GAA (0.50) | GAASTAT3ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL3133897 | 0.82 | PSIP1 (0.45) | ALDH1A1LMNAHPGDCA1CA9 | |
| SCHEMBL2627777 | 0.81 | ALDH1A1 (0.43) | GAASTAT3ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL18125563 | 0.81 | ALDH1A1 (0.43) | GAASTAT3ALDH1A1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543243-B1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL DERIVATIVES | AQDOT LTD (GB) | 2022-02-02 | — | — | EP | claimed |
| CN-110099904-A | Process for preparing cucurbituril derivatives | 爱客多有限公司 | 2019-08-06 | — | — | CN | claimed |
| US-RE38934-E1 | Method and reagents for N-alkylating ureides | TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2006-01-10 | — | — | US | claimed |
| US-20040167358-A1 | Method and reagents for N-alkylating ureides | GUTMAN DANIELA (IL) | 2004-08-26 | — | — | US | claimed |
| EP-1027339-B1 | METHOD AND REAGENTS FOR N-ALKYLATING UREIDES | TARO PHARMA IND (IL) | 2004-01-02 | — | — | EP | claimed |
| EP-1342718-A1 | Method and reagents for n-alkylating ureides | TARO PHARMACEUTICAL INDUSTRIES LIMITED (IL) | 2003-09-10 | — | — | EP | claimed |
| US-20030018080-A1 | N-methoxymethyl-5,5-diphenylbarbituric acid | TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2003-01-23 | — | — | US | claimed |
| CN-1273581-A | Process and reagent for N-alkylation of ureides | TARO PHARMA IND (IL) | 2000-11-15 | — | — | CN | claimed |
| US-6093820-A | REACTING AN IMIDE WITH A (SUBSTITUTED)ALKOXYALKYLSULFONIC ACID ESTER TO FORM A N-ALKOXYALKYL IMIDE SUCH AS METHOXYMETHYL ETHOSUXIMIDE; ADMINISTERING AS ANTICONVULSANT, ANTIANXIETY AGENT AND MUSCLE RELAXANT | TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2000-07-25 | — | — | US | claimed |
| US-4247461-A | Esterification process using methoxymethyl-P-toluenesulfonate | BRISTOL-MYERS COMPANY (US) | 1981-01-27 | — | — | US | claimed |
| US-4219495-A | ESTERIFYING AGENT FOR CEPHALOSPORIN AND PENICILLIN CARBOXYL GROUPS | BRISTOL-MYERS COMPANY (US) | 1980-08-26 | — | — | US | claimed |
| CN-119569637-A | Method for synthesizing 2, 3-trimethyl indole quaternary ammonium salt by one-pot process | 中国乐凯集团有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-11753547-B2 | Near-infrared absorbing composition, near-infrared absorbing film, and image sensor for solid-state imaging element | Konica Minolta, Inc. (JP) | 2023-09-12 | — | — | US | disclosed |
| CN-110099904-A | Process for preparing cucurbituril derivatives | 爱客多有限公司 | 2019-08-06 | — | — | CN | disclosed |
| US-10265325-B2 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment | NEURODYN LIFE SCIENCES INC. (CA) | 2019-04-23 | — | — | US | disclosed |
| US-4247461-A | Esterification process using methoxymethyl-P-toluenesulfonate | BRISTOL-MYERS COMPANY (US) | 1981-01-27 | — | — | US | disclosed |
| US-4247461-A | Esterification process using methoxymethyl-P-toluenesulfonate | BRISTOL-MYERS COMPANY (US) | 1981-01-27 | — | — | US | disclosed |
| US-4219495-A | ESTERIFYING AGENT FOR CEPHALOSPORIN AND PENICILLIN CARBOXYL GROUPS | BRISTOL-MYERS COMPANY (US) | 1980-08-26 | — | — | US | disclosed |
| US-4219495-A | ESTERIFYING AGENT FOR CEPHALOSPORIN AND PENICILLIN CARBOXYL GROUPS | BRISTOL-MYERS COMPANY (US) | 1980-08-26 | — | — | US | disclosed |
| US-4219495-A | ESTERIFYING AGENT FOR CEPHALOSPORIN AND PENICILLIN CARBOXYL GROUPS | BRISTOL-MYERS COMPANY (US) | 1980-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018080-A1 | N-methoxymethyl-5,5-diphenylbarbituric acid | MGMT, ALKBH3, ALKBH5 | GAA 2329/4885STAT3 3526/4885ALDH1A1 406/4885 |
| US-10265325-B2 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment | CHAT, SLC18A3, CHRNB2 | GAA 453/4885STAT3 3054/4885ALDH1A1 4471/4885 |
| US-20040167358-A1 | Method and reagents for N-alkylating ureides | MGMT, ETV6, ALKBH3 | GAA 2491/4885STAT3 4018/4885ALDH1A1 839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.